Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2020 | Story André Damons
Bongani Mayosi Prize Latest News
Drs Kaamilah Joosub (in front) and Lynette Upman, medical students in the Faculty of Health Sciences at the UFS, are the winners of the first Bongani Mayosi Medical Students Academic Prize for final-year medical students.

Two final-year medical students from the University of the Free State (UFS) became the first recipients of the prestigious Bongani Mayosi Medical Students Academic Prize which was bestowed on them 10 days before their graduation.

Drs Kaamilah Joosub and Lynette Upman, two final-year medical students in the Faculty of Health Sciences at the UFS are the first medical students from the university to be awarded the prize.This is the first year it has been awarded.

Drs Joosub and Upman received their awards at a function on Friday (4 December 2020) from Prof Hanneke Brits, Phase III chair and specialist in the Department of Family Medicine, on behalf of Prof Gert van Zyl, Dean of the Faculty of Health Sciences.

The Faculty of Health Sciences will host a virtual graduation on 14 December 2020.

Prestigious national award

The Bongani Mayosi Medical Students Academic Prize is a prestigious national award which aims to recognise final-year medical students who epitomise the academic, legendary, and altruistic life of Mayosi. The awards are presented to final-year MB ChB students from all South African medical faculties. Each student is allowed one vote for one classmate who, in their private opinion, best balances:

  • Academic achievement
  • Emotional intelligence ‑ good interpersonal skills
  • Social accountability ‑ the ability to respond helpfully to the needs of others

Winners are determined by the highest number of digital votes, with the first-prize winner receiving R6 000 and second prize coming in at R4 000.

Dr Lynette van der Merwe, undergraduate medical programme director in the School of Clinical Medicine at UFS, commented that Drs Joosub and Upman are worthy winners, as they have continuously exemplified the ideals recognised by this award during their undergraduate training.

The School of Clinical Medicine is very proud of its newest Kovsie doctors who successfully completed the academic year despite the immense challenges associated with the COVID-19 pandemic. This is thanks to the commitment and hard work of students and staff at the UFS. 

Name behind the prize

The late Prof Bongani Mayosi was an outstanding doctor who rose rapidly through the ranks to become a top cardiologist, internationally recognised as a leading clinician scientist. He completed his undergraduate studies at the age of 22, having graduated cum laude in both the Bachelor of Medicine and Surgery (MB ChB) and Bachelor of Medical Sciences (BMedSci) degrees.

He trained as a physician and cardiologist at Groote Schuur Hospital and completed his doctorate at the University of Oxford in the UK. At the age of 38‚ he became the first black to be appointed professor and Head of the Department of Medicine at the University of Cape Town (UCT). In 2016, he was appointed Dean of the Faculty of Health Sciences at UCT. Before taking up his deanship, he completed the Advanced Management Programme at Harvard University in the US.

As a medical student Prof Mayosi excelled academically, was supportive of his classmates and enthusiastically involved in student residence committees and politics as well as community outreach programmes. As a researcher, he initiated an international programme of research focusing on solutions for poverty-related heart diseases and trained local clinician scientists and research leaders.

Prof Mayosi had an exceptional mixture of academic brilliance and vision; ambition and humility; kindness and generosity; passion and compassion; drive and empathy that complemented his ability to persuade and inspire others, which no doubt contributed to his 400 publications.

 

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept